The study was the first head-to-head trial to compare 2 common options for treatment to prevent recurrent venous thromboembolism. For patients who have experienced a life-threatening blood clot, ...

Pexidartinib is an oral small molecule that is believed to work by inhibiting colony stimulating factor-1 receptor (CSF1R). Both doses of Xarelto (10mg and 20mg) were superior to aspirin (100mg) in ...

XARELTO (rivaroxaban) 20mg tablets Results of a study conducted by Janssen show that prothrombin complex concentrates can reverse the blood thinning effects of Xarelto (rivaroxaban) in healthy ...

A new phase III trial shows that Bayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto is more effective than aspirin at preventing recurrent blood clots, with no increase in bleeding risk. The ...

LONDON, April 12 (Reuters) - Bayer's (BAYGn.DE), opens new tab patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker.

Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved product is ...